1 to 5 of 5 Results
Mar 3, 2025 - Andrea Ciaranello Dataverse
Rosen, Linzy, 2025, "Dataverse submission for Tuberculosis Preventive Treatment for Pregnant People with HIV in South Africa: a Modeling Analysis of Clinical Benefits and Risks", https://doi.org/10.7910/DVN/TOZRUT, Harvard Dataverse, V1
These materials are from an analysis funded in part by the National Institutes of Health. We are sharing these on the Harvard Dataverse in compliance with the Data Sharing and Management Plan associated with support from R37 HD079214 (PI: Ciaranello). The full analysis has been published in Clin Infect Dis, and relevant components of the published... |
Mar 3, 2025
Dr. Andrea Ciaranello's CEPAC-Pediatrics modeling team at the Mass General Hospital MPEC Research Group uses microsimulation modeling and cost-effectiveness analyses to improve health outcomes for mothers and babies affected by HIV. |
Dec 3, 2021
Ingrid Bassett, MD, MPH, is investigating ways to expand access to HIV testing, treatment and prevention in South Africa, the epicenter of the HIV epidemic. |
Dec 2, 2021 - Mark Siedner Dataverse
Siedner. Mark, 2021, "REVAMP Clinical Trial Dataset", https://doi.org/10.7910/DVN/SKUUOP, Harvard Dataverse, V1, UNF:6:+8OM8WiRXHVT7hNESHIeWA== [fileUNF]
Data are derived from the Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa (REVAMP) clinical trial. The de-identified dataset includes include randomization allocation, baseline participant characteristics and primary and secondary outcomes. |
Dec 2, 2021
Our research program, based in Mbarara, Uganda and Durban, South Africa, aims to improve health and quality of life for people living with HIV in low-income countries. This program of work includes: 1) clinical trials to evaluate scalable interventions to improve HIV care delivery, and reduce treatment failure and drug resistance 2) translational r... |